VitaNova Life Sciences Corp (VNOV) stock
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
VitaNova Life Sciences's profit margin for the twelve months ending Jul 31, 2026 was -3.5%. For fiscal 2026 it was -1.2%, against 32.0% the year before. The highest annual figure on record is 116.4% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -1.2% | −33.2 |
| FY2025 | Apr 30, 2025 | 32.0% | +7.3 |
| FY2024 | Apr 30, 2024 | 24.7% | +88.4 |
| FY2023 | Apr 30, 2023 | -63.8% | −180.2 |
| FY2022 | Apr 30, 2022 | 116.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -38.3% | +6.3 |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | 1.0% | −40.0 |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | -6.3% | −29.9 |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | 8.4% | −2.8 |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -44.6% | +6.3 |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | 41.0% | +10.1 |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | 23.7% | +0.9 |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | 11.2% | +157.3 |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -50.9% | +194.9 |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | 30.8% | +4.8 |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | 22.8% | +8.6 |
| Q4 FY2023CQ1 2023 | Apr 30, 2023 | -146.2% | −86.6 |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | -245.8% | −275.5 |
| Q2 FY2023CQ3 2022 | Oct 31, 2022 | 26.0% | −7.3 |
| Q1 FY2023CQ2 2022 | Jul 31, 2022 | 14.2% | – |
| Q4 FY2022CQ1 2022 | Apr 30, 2022 | -59.6% | – |
| Q3 FY2022CQ4 2021 | Jan 31, 2022 | 29.7% | – |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | 33.4% | – |
See a number that looks wrong?